Alexandra Schratter
YOU?
Author Swipe
View article: 2025 International Expert Practical Guide on the Use of the Pentaspline Pulsed Field Ablation System in Atrial Fibrillation Ablation Procedures
2025 International Expert Practical Guide on the Use of the Pentaspline Pulsed Field Ablation System in Atrial Fibrillation Ablation Procedures Open
Pulsed field ablation (PFA) has been developed as a largely nonthermal ablation technology with a unique biophysical profile to treat atrial fibrillation. Existing evidence has shown that PFA offers a safe and efficient atrial fibrillation…
View article: Patients with paroxysmal atrial fibrillation undergoing left atrial appendage closure
Patients with paroxysmal atrial fibrillation undergoing left atrial appendage closure Open
Introduction There is limited evidence regarding outcome in patients with paroxysmal vs. persistent atrial fibrillation (AF) undergoing left atrial appendage closure (LAAC). Methods A retrospective analysis from a multicentre registry incl…
View article: Cold aortic flush after ventricular fibrillation cardiac arrest reduces inflammatory reaction but not neuronal loss in the pig cerebral cortex
Cold aortic flush after ventricular fibrillation cardiac arrest reduces inflammatory reaction but not neuronal loss in the pig cerebral cortex Open
View article: Percutaneous retrieval via transseptal access of an Amplatzer Amulet left atrial appendage closure device embolized in the left ventricle
Percutaneous retrieval via transseptal access of an Amplatzer Amulet left atrial appendage closure device embolized in the left ventricle Open
View article: Effects of sodium–glucose co‐transporter inhibitors on individual clinical endpoints and quality of life
Effects of sodium–glucose co‐transporter inhibitors on individual clinical endpoints and quality of life Open
Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk fa…
View article: Left Atrial Appendage Closure in Atrial Fibrillation Patients with Cancer
Left Atrial Appendage Closure in Atrial Fibrillation Patients with Cancer Open
Background: There are limited data about left atrial appendage closure (LAAC) in patients with cancer. We therefore sought to compare the outcome after LAAC in patients with vs. without cancer in a multicentre registry. Methods: In this su…
View article: Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of > 80,000 patients (the SGLT2i—Arrhythmias and Sudden Cardiac Death)
Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of > 80,000 patients (the SGLT2i—Arrhythmias and Sudden Cardiac Death) Open
Objective We aimed to assess the effect of SGLT2i on arrhythmias by conducting a meta-analysis using data from randomized controlled trials(RCTs). Background Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have shown cardioprotective e…
View article: Size matters - body size and acute device-implantation failure after LAAC
Size matters - body size and acute device-implantation failure after LAAC Open
Funding Acknowledgements Type of funding sources: None. Introduction Patient-device mismatch in patients undergoing left atrial appendage closure (LAAC) may lead to failure to implant, dislocation, and cardiac tamponade. There is limited d…
View article: Evolving Role of Catheter Ablation for Atrial Fibrillation: Early and Effective Rhythm Control
Evolving Role of Catheter Ablation for Atrial Fibrillation: Early and Effective Rhythm Control Open
Catheter Ablation (CA) is an effective therapeutic option in treating atrial fibrillation (AF). Importantly, recent data show that CA as a rhythm control strategy not only significantly reduces AF burden, but also substantially improves cl…
View article: Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study Open
Bayer.
View article: Low haemoglobin is associated with increased risk of complications in left atrial appendage closure patients
Low haemoglobin is associated with increased risk of complications in left atrial appendage closure patients Open
Introduction Left atrial appendage closure is associated with a relevant procedural complication rate. Baseline risk factors, such as pre-procedural lab results, may identify patients that develop acute complications. Methods We performed …
View article: Comparison of Left Atrial Appendage Occlusion versus Non-Vitamin-K Antagonist Oral Anticoagulation in High-Risk Atrial Fibrillation: An Update
Comparison of Left Atrial Appendage Occlusion versus Non-Vitamin-K Antagonist Oral Anticoagulation in High-Risk Atrial Fibrillation: An Update Open
Transcatheter left atrial appendage occlusion (LAAO) is non-inferior to vitamin K antagonists (VKAs) in preventing thromboembolic events in atrial fibrillation (AF). Non-vitamin K antagonists (NOACs) have an improved safety profile over VK…
View article: Association of Preoperative Renin-Angiotensin System Inhibitors With Prevention of Postoperative Atrial Fibrillation and Adverse Events
Association of Preoperative Renin-Angiotensin System Inhibitors With Prevention of Postoperative Atrial Fibrillation and Adverse Events Open
The findings from this study suggest that preoperative RASI treatment does not offer additional benefit in reducing the risk of POAF, stroke, death, and hospitalization in the setting of cardiac surgery. The results provide no support for …
View article: Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction Open
Ventricular tachycardia (VT) in patients with ischemic cardiomyopathy mainly results from endocardial scars after myocardial infarction; those scars represent zones of slow conduction that allow the occurrence and maintenance of reentrant …
View article: Electroanatomical high-density mapping of different tachycardias in the right atrium after heart transplantation
Electroanatomical high-density mapping of different tachycardias in the right atrium after heart transplantation Open
Tabled 1KEY TEACHING POINTS•Complex arrhythmias may occur especially after heart surgery.•Precise and differentiated mapping is crucial to identify and ablate complex tachycardias.•High-density mapping is made possible by the use of multip…
View article: Catheter Ablation of Ventricular Tachycardia and Mortality in Patients With Nonischemic Dilated Cardiomyopathy
Catheter Ablation of Ventricular Tachycardia and Mortality in Patients With Nonischemic Dilated Cardiomyopathy Open
Background— Data on outcomes after catheter ablation of ventricular tachycardia (VT) in patients with nonischemic dilated cardiomyopathy (NIDCM) are insufficient. We aimed to investigate the effects of successful catheter ablation of VT on…